CD44-mediated neutrophil apoptosis in the rat

Slides:



Advertisements
Similar presentations
Volume 70, Issue 7, Pages (October 2006)
Advertisements

Volume 60, Issue 3, Pages (September 2001)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 64, Issue 6, Pages (December 2003)
Volume 79, Issue 9, Pages (May 2011)
Volume 59, Issue 3, Pages (March 2001)
Volume 80, Issue 12, Pages (December 2011)
Volume 78, Issue 4, Pages (August 2010)
Volume 66, Issue 3, Pages (September 2004)
Volume 70, Issue 7, Pages (October 2006)
Volume 75, Issue 1, Pages (January 2009)
Volume 61, Issue 4, Pages (April 2002)
Volume 58, Issue 5, Pages (November 2000)
Volume 72, Issue 4, Pages (August 2007)
Volume 62, Issue 6, Pages (December 2002)
Volume 58, Issue 3, Pages (September 2000)
Volume 82, Issue 8, Pages (October 2012)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Volume 63, Issue 2, Pages (February 2003)
Volume 55, Issue 6, Pages (June 1999)
Volume 18, Issue 5, Pages (May 2010)
Volume 64, Issue 1, Pages (July 2003)
Volume 60, Issue 2, Pages (August 2001)
Volume 68, Issue 5, Pages (November 2005)
Volume 66, Issue 6, Pages (December 2004)
Volume 63, Issue 4, Pages (April 2003)
Regulation of apoptosis by lethal cytokines in human mesothelial cells
Volume 75, Issue 10, Pages (May 2009)
Volume 53, Issue 6, Pages (June 1998)
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Volume 63, Issue 1, Pages (January 2003)
Hyaluronan and proximal tubular cell migration
Volume 54, Issue 3, Pages (September 1998)
Volume 140, Issue 1, Pages e3 (January 2011)
Volume 63, Issue 4, Pages (April 2003)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 69, Issue 1, Pages (January 2006)
Volume 59, Issue 1, Pages (January 2001)
Volume 66, Issue 5, Pages (November 2004)
Volume 59, Issue 4, Pages (April 2001)
Volume 56, Issue 3, Pages (September 1999)
In vivo visualization of albumin degradation in the proximal tubule
Volume 58, Issue 5, Pages (November 2000)
Volume 81, Issue 9, Pages (May 2012)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 56, Issue 2, Pages (August 1999)
Volume 60, Issue 3, Pages (September 2001)
Volume 60, Issue 1, Pages (July 2001)
Volume 56, Issue 4, Pages (October 1999)
Volume 70, Issue 7, Pages (October 2006)
Volume 58, Issue 3, Pages (September 2000)
Volume 72, Issue 8, Pages (October 2007)
Volume 54, Issue 2, Pages (August 1998)
Jin H. Li, Xiao R. Huang, Hong-Jian Zhu, Richard Johnson, Hui Y. Lan 
Volume 63, Issue 4, Pages (April 2003)
Volume 57, Issue 3, Pages (March 2000)
Local macrophage proliferation in human glomerulonephritis
Volume 56, Issue 3, Pages (September 1999)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Volume 71, Issue 7, Pages (April 2007)
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Volume 65, Issue 6, Pages (June 2004)
Volume 57, Issue 2, Pages (October 2000)
Intrathymic T Cell Development and Selection Proceeds Normally in the Absence of Glucocorticoid Receptor Signaling  Jared F Purton, Richard L Boyd, Timothy.
Volume 58, Issue 3, Pages (September 2000)
Volume 63, Issue 1, Pages (January 2003)
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
Volume 61, Issue 2, Pages (February 2002)
Volume 57, Issue 5, Pages (May 2000)
Presentation transcript:

CD44-mediated neutrophil apoptosis in the rat Kazunori Takazoe, Gregory H. Tesch, Prue A. Hill, Lyn A. Hurst, Zhao Jun, Hui Y. Lan, Robert C. Atkins, David J. Nikolic-Paterson  Kidney International  Volume 58, Issue 5, Pages 1920-1930 (November 2000) DOI: 10.1111/j.1523-1755.2000.00364.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 CD44 expression by rat blood leukocytes. Cells were labeled with 73.5 (control), OX-50, A2.6, or OX-1 antibodies, as indicated, and were analyzed by flow cytometry. Cells were gated for neutrophils (A–D) and lymphocytes (E–H). The percentage of positive cells (in parenthesis) was determined by a cutoff (vertical line) based on the results of the negative control antibody (73.5). Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Anti-CD44 antibody induces neutrophil apoptosis in vitro. Rat blood leukocytes were cultured for 60 minutes in RPMI with 5% FCS in the presence of different antibodies. Cells were then incubated with annexin V-FITC (AV, FL1) and propidium iodide (PI, FL3) and were analyzed by two-color flow cytometry. The neutrophil population was gated on the basis of forward light scatter (FSC) versus 90° side scatter (SSC). The fluorescence profiles were determined for the gated cells. (A and B) 73.5 control antibody. (C and D) OX-50 antibody. Values in the fluorescence scattergrams represent the percentage of cells within each quadrant. (E) Quantitation of the percentage of apoptotic neutrophils (AV+PI- cells). Data are mean ± SD from six experiments. **P < 0.01 vs. control by Dunnett's multiple comparison test (ANOVA). Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Transmission electron microscopy of OX-50 antibody–induced neutrophil apoptosis. Rat blood leukocytes were cultured for 60 minutes with the OX-50 antibody and were then processed for electron microscopy. Several neutrophils (N) are seen in the process of apoptosis. There is condensation of the cytoplasm with dilation of the endoplasmic reticulum. The nuclei show profound peripheral chromatin condensation and have broken up into rounded bodies. The neutrophil at the top of the figure demonstrates early pinching off of a membrane-bound near spherical body (arrow). The lymphocyte (L) shows no evidence of apoptosis (×9450). Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Effect of cross-linking on CD44-mediated neutrophil apoptosis in vitro. Rat blood leukocytes were incubated for 60 minutes at 37°C with OX-50 IgG, OX-50 F(ab) fragments, high molecular weight hyaluronan (HMW HA; 500 μg/mL), or low molecular weight hyaluronan (LMW HA; 500 μg/mL), and apoptosis was analyzed by flow cytometry using annexin V-FITC and propidium iodide. Data are mean ± SD from three experiments. **P < 0.01 vs. 73.5 control by Dunnett's multiple comparison test (ANOVA). Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Flow cytometry analysis of CD44 expression by cultured mesangial and tubular epithelial cells. (A and B) Rat 1097 mesangial cells and (C and D) NRK52E tubular epithelial cells were cultured and then labeled with either a negative control antibody 73.5 (A and C) or with the anti-CD44 antibody OX-50 (B and D). Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Anti-CD44 monoclonal antibody (mAb) induces neutrophil apoptosis in vivo. Rats were killed 20 minutes after a single intravenous injection of 10 mg/kg purified IgG, and blood cells were analyzed by flow cytometry. In experiment 1, clear neutrophil (R1) and lymphocyte (R2) populations were seen on forward light scatter (FSC) versus 90° side scatter (SSC) histograms after an injection of the negative control 73.5 mAb (A); however, the neutrophil population (R1) was depleted after injection of the OX-50 mAb (B). In experiment 2, an injection of the OX-1 mAb, which binds to all leukocytes, had no effect on the neutrophil (R1) or lymphocyte (R2) populations (C); however, the administration of OX-50 mAb again caused a specific depletion of cells from the neutrophil (R1) gate (D). These data are representative of four separate experiments. Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 7 Transmission electron microscopy of OX-50 antibody-induced neutrophil apoptosis in vivo. Peripheral blood cells were prepared from a rat 20 minutes after intravenous injection of OX-50 mAb. The polymorphonuclear cell (P) is seen undergoing early apoptosis. The nucleus shows peripheral chromatin condensation, and the cytoplasm appears dark and condensed. The lymphocyte (L) shows no evidence of apoptosis. Magnification ×11,000. Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 8 Anti-CD44 mAb inhibits the induction of renal injury in rat glomerulonephritis. Accelerated anti-GBM glomerulonephritis was induced in groups of four animals that were treated with OX-50 (anti-CD44) or a control antibody before the administration of anti-GBM serum. Animals were killed on day 1. (A) Twenty-four–hour urinary protein excretion. (B) W3/13+ T-cells per glomerular cross-section (gcs). (C) ED1+ macrophages per gcs. (D) Blood neutrophil numbers at the time of anti-GBM serum injection. (E) Blood lymphocyte numbers at the time of anti-GBM injection. Data are mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 vs. normal; aP < 0.05; bP < 0.01 vs. OX-50 mAb treated by Tukey's multiple comparison test (ANOVA). Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 9 Anti-CD44 mAb fails to inhibit progression of renal injury in rat glomerulonephritis. Accelerated anti-GBM glomerulonephritis was induced in groups of six animals that were treated with OX-50 (anti-CD44) or a control antibody before administration of anti-GBM serum and every second day thereafter until being killed on day 10. (A) Twenty-four–hour urinary protein excretion. (B) W3/13+ T cells per glomerular cross-section (gcs). (C) ED1+ macrophages per gcs. (D) A 24-hour skin DTH response shown as the change in skin thickness. Data are mean ± SD from groups of six animals. *P < 0.05; **P < 0.01; ***P < 0.001 vs. normal; and aP < 0.05; bP < 0.01; cP < 0.001 vs. OX-50 treated by t-test (a and d) or Tukey's multiple comparison test (ANOVA; b and c). Kidney International 2000 58, 1920-1930DOI: (10.1111/j.1523-1755.2000.00364.x) Copyright © 2000 International Society of Nephrology Terms and Conditions